Will the EPO’s Enlarged Board of Appeal Hear the Broad's CRISPR Case?
In: Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018. https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case
Posted: 4 Sep 2020 Last revised: 8 Sep 2020
Date Written: July 13, 2018
Abstract
As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
Suggested Citation: Suggested Citation
Wested, Jakob and Minssen, Timo and van Zimmeren, Esther, Will the EPO’s Enlarged Board of Appeal Hear the Broad's CRISPR Case? (July 13, 2018). In: Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018.
https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case
, Available at SSRN: https://ssrn.com/abstract=3653160
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.